Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-18

FDA Approved: SITAGLIPTIN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a sitagliptin product under an Original Application from Zydus Lifesciences Limited for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

ORIG AP for SITAGLIPTIN (SITAGLIPTIN)